Orient successfully borrowed the southwestern pharmaceutical industry (600666), and the lurking gold system of the long-term has also shared this capital feast. After more than four months of suspension, Southwest Pharmaceuticals released a restructuring plan for the listing of Harbin Orient Optoelectronics Technology Co., Ltd. on August 11. With Orient's sapphire business, Southwest Pharmaceuticals has continuously harvested seven daily limit boards after the resumption of trading. The transaction plan shows that Orient has 35 natural person shareholders and 12 investment institution shareholders. Among them, Shanghai Xianghe and Shanghai Yucheng are both subsidiaries of “Yongjinâ€, each holding Orient 9.02%. , 16.07% of the shares. If the initial investment is 26.52 million yuan and 14.89 million yuan, and the value of the equity of Yongjin is 1 billion yuan, the investment income has nearly 25 times.
Southwest Pharmaceutical stock price doubled seven even board <br> <br> Southwest Pharmaceutical (600,666) yesterday morning again no suspense, "a" word limit board, since August 12, the stock has 7 consecutive days Daily limit. As of yesterday, the Southwest Pharmaceuticals reported a daily limit of 14.23 yuan, or 9.97%. The stock price has soared 94.66% since the suspension on April 24.
After more than four months of suspension, Southwest Pharmaceuticals announced on August 11 that Harbin Orient Optoelectronics Technology Co., Ltd. has restructured its backdoor listings, intending to pass a major asset swap, issue shares to purchase assets, share transfers, etc. Trading, the realization of Orient's backdoor southwest pharmaceutical listing.
According to the restructuring plan, Southwest Pharmaceutical intends to use its entire assets and liabilities (net of accumulated undistributed profits) for a price of 427 million yuan, and replace it with the equivalent of the shares held by Zuo Hongbo, one of the actual controllers of Orient. After the completion of the replacement, Southwest Pharmaceutical will issue 498 million shares to all Orient shareholders at 7.42 yuan/share, and then acquire 100% of Orient. The latter's overall estimate is 4.12 billion yuan.
According to the announcement, Orient's value-added is nearly six times higher than the net book value of Orchard's parent company of RMB 59,637,400 on April 30, 2014. According to industry insiders, this is equivalent to more than 50 times the price-earnings ratio at the end of 2013, and the net assets premium is six times. If you have a reasonable valuation, you have to ask a question mark.
Such a high valuation may be related to Orient's production of sapphire "the market outlook is seen". Sapphire products are considered the preferred material for next-generation mobile phone screens. It is reported that Southwest Pharmaceuticals will raise 1.03 billion yuan at a reserve price of 7.42 yuan/share, and the fund-raising amount will not exceed 25% of the total transaction amount for the relevant sapphire project. After the completion of the restructuring, Southwest Pharmaceuticals will be transformed into a supplier of sapphire crystal materials.
Yongjin turned 25 times the market value of shares <br> <br> Aorui De backdoor listing success, let latent institutions which benefit quite good. The transaction plan shows that Orient has 35 natural person shareholders and 12 investment institution shareholders. Among them, Shanghai Xianghe and Shanghai Yucheng are both subsidiaries of “Yongjinâ€, each holding Orient 9.02%. , 16.07% of the shares. Its value is 370 million yuan, 660 million yuan, a total of 1.03 billion yuan.
When the concept of sapphire was popular, the price of Orient was also rising. According to the announcement issued by Taiji Pharmaceutical, on April 30, 2014, the estimated value of Orient's 100% equity was 4.12 billion yuan, the net book value of the parent company was 596 million yuan, and the estimated value added was 3.52 billion yuan. The rate is 590.84%.
Behind the high premium is a capital feast for 33 shareholders of Orient and 12 institutions. After the successful completion of the issuance, the value of the 16.07% and 9.02% shares held by Shanghai Yongcheng and Shanghai Xianghe, both of the companies in the Aurora Group, are up to 1 billion yuan. If compared with the initial investment of 26.52 million yuan and 14.89 million yuan, each turned nearly 25 times.
The popularity of the sapphire concept stems from market rumors. It is reported that Origen (21.44, -0.16, -0.74%) sapphire products are considered the preferred material for the next generation of mobile phone screens, and the market prospect is good. It is reported that the new generation of iPhone collection will be launched next month, but there is no agreement on whether Apple uses sapphire products. Analysts at Jibang Technology said that they have not seen any Apple supply chain orders for sapphire glass, so this suggests that Apple may still use the existing Corning Gorilla glass panels on the iPhone 6.
As a new thing, the market prospects of sapphire are full of great uncertainty. In 2012, Orient's operating income increased by 89.14% year-on-year, but net profit decreased by 57.22% year-on-year to 175.01 million yuan. Ored said that this was due to a sharp drop in product prices. As the LED substrate industry's demand for sapphire crystal materials grew less than expected, the increase in demand was less than the growth of sapphire supply, resulting in the continued decline in sapphire market prices in 2012.
Although the sapphire price fluctuates widely, the industry still has high expectations for this new product. Zhang Jun, an analyst at Qilu Securities, said that after a series of expansions in 2014, Orient's production scale has reached 2.5 million mm / month, and will reach 5.5 million mm / month at the end of the year. In addition, on August 1, 2014, Orient started construction of a sapphire window material project with a total investment of 1.56 billion yuan in Qitaihe, Heilongjiang. The two phases of the project invested 950 sapphire growth furnaces. After completion, the production capacity reached 9.5 million mm/month. .
Southwest Pharmaceutical stock price doubled seven even board <br> <br> Southwest Pharmaceutical (600,666) yesterday morning again no suspense, "a" word limit board, since August 12, the stock has 7 consecutive days Daily limit. As of yesterday, the Southwest Pharmaceuticals reported a daily limit of 14.23 yuan, or 9.97%. The stock price has soared 94.66% since the suspension on April 24.
After more than four months of suspension, Southwest Pharmaceuticals announced on August 11 that Harbin Orient Optoelectronics Technology Co., Ltd. has restructured its backdoor listings, intending to pass a major asset swap, issue shares to purchase assets, share transfers, etc. Trading, the realization of Orient's backdoor southwest pharmaceutical listing.
According to the restructuring plan, Southwest Pharmaceutical intends to use its entire assets and liabilities (net of accumulated undistributed profits) for a price of 427 million yuan, and replace it with the equivalent of the shares held by Zuo Hongbo, one of the actual controllers of Orient. After the completion of the replacement, Southwest Pharmaceutical will issue 498 million shares to all Orient shareholders at 7.42 yuan/share, and then acquire 100% of Orient. The latter's overall estimate is 4.12 billion yuan.
According to the announcement, Orient's value-added is nearly six times higher than the net book value of Orchard's parent company of RMB 59,637,400 on April 30, 2014. According to industry insiders, this is equivalent to more than 50 times the price-earnings ratio at the end of 2013, and the net assets premium is six times. If you have a reasonable valuation, you have to ask a question mark.
Such a high valuation may be related to Orient's production of sapphire "the market outlook is seen". Sapphire products are considered the preferred material for next-generation mobile phone screens. It is reported that Southwest Pharmaceuticals will raise 1.03 billion yuan at a reserve price of 7.42 yuan/share, and the fund-raising amount will not exceed 25% of the total transaction amount for the relevant sapphire project. After the completion of the restructuring, Southwest Pharmaceuticals will be transformed into a supplier of sapphire crystal materials.
Yongjin turned 25 times the market value of shares <br> <br> Aorui De backdoor listing success, let latent institutions which benefit quite good. The transaction plan shows that Orient has 35 natural person shareholders and 12 investment institution shareholders. Among them, Shanghai Xianghe and Shanghai Yucheng are both subsidiaries of “Yongjinâ€, each holding Orient 9.02%. , 16.07% of the shares. Its value is 370 million yuan, 660 million yuan, a total of 1.03 billion yuan.
When the concept of sapphire was popular, the price of Orient was also rising. According to the announcement issued by Taiji Pharmaceutical, on April 30, 2014, the estimated value of Orient's 100% equity was 4.12 billion yuan, the net book value of the parent company was 596 million yuan, and the estimated value added was 3.52 billion yuan. The rate is 590.84%.
Behind the high premium is a capital feast for 33 shareholders of Orient and 12 institutions. After the successful completion of the issuance, the value of the 16.07% and 9.02% shares held by Shanghai Yongcheng and Shanghai Xianghe, both of the companies in the Aurora Group, are up to 1 billion yuan. If compared with the initial investment of 26.52 million yuan and 14.89 million yuan, each turned nearly 25 times.
The popularity of the sapphire concept stems from market rumors. It is reported that Origen (21.44, -0.16, -0.74%) sapphire products are considered the preferred material for the next generation of mobile phone screens, and the market prospect is good. It is reported that the new generation of iPhone collection will be launched next month, but there is no agreement on whether Apple uses sapphire products. Analysts at Jibang Technology said that they have not seen any Apple supply chain orders for sapphire glass, so this suggests that Apple may still use the existing Corning Gorilla glass panels on the iPhone 6.
As a new thing, the market prospects of sapphire are full of great uncertainty. In 2012, Orient's operating income increased by 89.14% year-on-year, but net profit decreased by 57.22% year-on-year to 175.01 million yuan. Ored said that this was due to a sharp drop in product prices. As the LED substrate industry's demand for sapphire crystal materials grew less than expected, the increase in demand was less than the growth of sapphire supply, resulting in the continued decline in sapphire market prices in 2012.
Although the sapphire price fluctuates widely, the industry still has high expectations for this new product. Zhang Jun, an analyst at Qilu Securities, said that after a series of expansions in 2014, Orient's production scale has reached 2.5 million mm / month, and will reach 5.5 million mm / month at the end of the year. In addition, on August 1, 2014, Orient started construction of a sapphire window material project with a total investment of 1.56 billion yuan in Qitaihe, Heilongjiang. The two phases of the project invested 950 sapphire growth furnaces. After completion, the production capacity reached 9.5 million mm/month. .
Power Distribution Board Range from the mini one to the bigger one, The Rated currect up to 300A, over 5 models and accept custom design of the power Distribution Board.
Power Distribution Board
Pdb Board,Distribution Board,Distribution Panel Board,Drone Power Distribution Board,Power HUB
shenzhen GC Electronics Co.,Ltd. , https://www.jmrdrone.com